KPV Reference Guide

Compound Reference Overview

Field Value
Name KPV (Lys-Pro-Val)
Reference Code KPV
Category Healing & Recovery Peptide
Example Strength 10 mg vial (varies by formulation)
Reference Range 200–500 mcg daily (investigational use)
Frequency Once daily
Key Safety Warning Anti-inflammatory fragment of α-MSH. Not FDA-approved for systemic injectable use. Use caution in pregnancy/breastfeeding and in patients on immunosuppressive therapy.

Mechanism of Action (Educational)

KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). It retains anti-inflammatory signaling properties without melanogenic (tanning) effects.

Preclinical data suggest KPV may reduce pro-inflammatory cytokine production, modulate NF-κB signaling, and support mucosal immune balance.

Most literature involves topical, gastrointestinal, or experimental inflammatory models. Systemic injectable use remains investigational.

Indications (Investigational / Literature)

  • Inflammatory bowel disease research
  • Skin inflammation models
  • Systemic inflammatory signaling research

Administration (Investigational)

Parameter Details
Route Subcutaneous
Frequency Once daily
Injection Site Abdomen
Timing Any time of day

Pharmacokinetics (Limited Human Data)

Comprehensive human pharmacokinetic data are limited. Biologic activity is typically described within hours, with anti-inflammatory effects reported over 1–2 weeks in investigational contexts.

Titration Schedule (Investigational)

No formal titration schedule is typically required. Reference dosing ranges from 200–500 mcg daily. Dose selection may be individualized based on tolerability and clinical framework.

Reconstitution & Concentration
(Mathematical Standardization Model)

For educational standardization purposes, a 10 mg vial reconstituted with 2 mL diluent yields:
5 mg/mL (5000 mcg/mL).

Parameter Value
Diluent Bacteriostatic water (example only)
Example Reconstitution 10 mg + 2 mL diluent
Resulting Concentration 5 mg/mL (5000 mcg/mL)
Stability Up to 28 days refrigerated (2–8°C; varies by formulation)

Conversion Reference

  • 0.04 mL (4 units) = 200 mcg
  • 0.08 mL (8 units) = 400 mcg
  • 0.10 mL (10 units) = 500 mcg

This section is provided strictly for arithmetic illustration and does not constitute dosing guidance.

Safety & Contraindications (Summary)

Contraindications

  • Pregnancy or breastfeeding
  • Known hypersensitivity

Drug Interactions

  • Immunosuppressants (mild): Potential additive immunomodulatory effects

Adverse Events

  • Injection site reactions
  • Mild gastrointestinal upset

Serious Adverse Events

  • Rare in limited investigational reports

Monitoring (Investigational)

  • Inflammatory markers (if applicable)
  • GI symptom tracking
  • Skin condition changes
  • General tolerance

Mathematical Calculation Tool

The calculator below allows mathematical concentration and volume calculations using variable vial strengths and reconstitution volumes. This tool is provided strictly for arithmetic reference.

Peptide Reconstitution Calculator

For Educational & Professional Reference Only

⚠️ This is a mathematical reference tool only. No medical or dosing advice is provided.

Disclaimer

KPV is not FDA-approved for systemic injectable use. This content is provided strictly as a pharmacologic and mathematical reference for educational and professional purposes. It does not constitute medical advice or prescribing guidance. All clinical decisions must be made by a licensed healthcare professional in accordance with applicable regulations.

Reference Sources